Cultural rationales guiding medication adherence among African American with HIV/AIDS

AIDS Patient Care and STDs

Volumn 25, Issue 9, 2011, Pages 547-555

  Sankar, Andrea ^a   Neufeld, Stewart ^a   Berry, Rico ^b   Luborsky, Mark ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; AFRICAN AMERICAN; ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; SOCIAL BELIEF; VIRUS LOAD;

ADULT; AFRICAN AMERICANS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CULTURE; DATA COLLECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; UNITED STATES; VIRAL LOAD;

EID: 80051987050     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2010.0345     Document Type: Article

References (53)

1. Horne R. Adherence to medication: A review of existing research. In Myers LB, Midence K, eds. Adherence to Treatment in Medical Conditions. Amsterdam: Overseas Publishers Assoc., 1998:285-311.
2. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26: 331-342. (Pubitemid 32989555)
3. McMullen K, Luborsky M. Self-rated health as cultural and identity appraisal process: African-American elders health evaluative rationales. Gerontologist 2006;46:431-438. (Pubitemid 44384690)
4. Spire B, Duran S, Souville M. Adherence to highly active antiretroviral therapies (ART) in HIV-infected patients: From a predictive to a dynamic approach. Soc Sci Med 2002; 54:1481-1496. (Pubitemid 34309013)
5. Preau M, Vincent E, Spire B, et al. Health-related quality of life and health locus of control beliefs among HIV-infected treated patients. J Psychosom Res 2005;59:407-413. (Pubitemid 41676898)
6. Reimen R, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Lee GM. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV + men and women in four U.S cites. AIDS Behav 2003;7:61-72. (Pubitemid 36578367)
7. Sankar A, Wunderlich T, Neufeld S, Luborsky M. Seropositive African American beliefs about alcohol and impact on antiretroviral adherence. AIDS Behav 2006;10:1-9.
8. Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with nonadherence to HAART. Int J STD AIDS 2004;15:38-44. (Pubitemid 38096128)
9. Pound P, Britten N, Morgan M, et al. Resisting medicines: A synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61:133-155. (Pubitemid 40545066)
10. Centers for Disease Control and Prevention. Fact Sheet: HIV/AIDS among African Americans, CDC 2008. Rev ed., Atlanta: Centers for Disease Control and Prevention, 2008.
11. Jain S, Schwarcz S, Katz M, Gulati R, McFarland W. Elevated risk of death for African Americans with AIDS, San Francisco, 1996-2002. J Health Care Poor Underserv 2006;17:493-503. (Pubitemid 44432408)
12. Giordano TP, Bartsch G, Zhang Y, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) Trail. AIDS Patient Care STDs 2010;24:287-295.
13. Asad S, Hulgan T, Raffanti SP, Daugherty J, Ray W, Sterling TR. Socio-demographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors. J Natl Med Assoc 2008;100:1417-1424.
14. Weidle PJ, Ganea CE, Irwin KL. Adherence to antiretroviral medications in an inner-city population. J Acquir Immune Defic Syndr 1999;22:498-502. (Pubitemid 30027501)
15. Bohnert AS, Latkin CA. HIV testing and conspiracy beliefs regarding the origins of HIV among African Americans. AIDS Patient Care STDs 2009;23:759-763.
16. Bogart L, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr 2005;38:213-218. (Pubitemid 40189330)
17. Oh DL, Sarafian F, Silvestre A, et al. Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among white Hispanic and Black men in the MACS cohort. J Acquir Immune Defic Syndr 2009;52:290-293.
18. Saha S, Jacobs EA, Moore RD, Beach MC. Trust in physicians and racial disparities in HIV care, AIDS Patient Care STDs 2010;24:415-420.
19. Laws MB, Wilson IB, Bowser D, Keer SE. Taking antiretroviral therapy for HIV infection: Learning from patients stories. J Gen Intern Med 2000;15:848-858. (Pubitemid 32011834)
20. Reynolds N, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons new to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav 2004;8:141-150. (Pubitemid 38888108)
21. Golin, CE, Liu, H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002;17:756-765. (Pubitemid 35286241)
22. Walsh JC, Horne R, Dalton M, Burgess AP, Gazzard BG. Reasons for non-adherence to antiretroviral therapy: Patients perspectives provide evidence of multiple causes. AIDS Care 2001;13:709-720. (Pubitemid 34014237)
23. Wong WKT, Ussher J. How do subjectively-constructed meanings ascribed to anti-HIV treatments affect treatmentadherent patients? Qual Health Res 2008;18:458-468. (Pubitemid 351420316)
24. Stevens PE, Hildebrandt E. Pill taking from the perspective of HIV-infected women who are vulnerable to antiretroviral treatment failure. Qual Health Res 2009;19:593-604.
25. Donovan JL. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care 1995;11:443-455.
26. Anderson J, Wiggens S, Rajwani R, Holbrook A, Blue C, Ng M. Living with a chronic illness: Chinese-Canadian and Euro-Canadian women with diabetes-Exploring factors that influence management. Soc Sci Med 1995;41:181-195.
27. Anderson R, Donnely M, David W. Controversial beliefs about diabetes and its care. Diabetes Care 1992;15:859-863.
28. Rosenstock I. The health belief model and preventative behavior. Health Educ Monogr 1974;2:354-386.
29. Baer H. The emergence of integrative medicine in Australia: The growing interest of biomedicine and nursing in complementary medicine in a southern developed society. Med Anthropol Q 2008;22:52-67.
30. Hunt L, Arar N. An analytical framework for contrasting patient and provider views of the process of chronic disease management. Med Anthropol Q 2001;15:1-21.
31. Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In Rachman S, ed. Contributions to Medical Psychology, Oxford: Pergamon Press, 1980, vol. 2, pp. 7-30.
32. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 1992;16:143-163.
33. Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with nonadherence to ART. Int J STD AIDS 2004;15:38.
34. Horne R, Weinman J. Patient beliefs about prescribed medications and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;46:555-567. (Pubitemid 30029305)
35. Trostle J, Hauser A, Susser I. The logic of noncompliance: Management of epilepsy from the patients point of view. J Clin Pharm Ther 1983;26:331-342.
36. Murray LK, Semrau K, McCurley E, et al. Barriers to acceptance and adherenece of antiretroviral therapy in urban Zambian women: A qualitative study. AIDS Care 2009;21: 78-86.
37. Sankar A, Luborsky M, Schuman P, Roberts G. Adherence discourseamongHIV+ AfricanAmericanwomen taking high acting anti-retroviral therapy. AIDS Care 2002;14:203-218.
38. Kleinman A. Patients and Healers in the Context of Culture. Berkeley: University of California Press, 1980.
39. Garro L. Explaining high blood pressure: Variation in knowledge about illness. Am Anthropol 1988;15:98-119.
40. Garro L. Individual or societal responsibility? Explanations of diabetes in an Anishinaabe (Ojibway) Community. Soc Sci Med 1995;40:37-46. (Pubitemid 24353140)
41. Hernandez C. The experience of living with Insulin-dependent diabetes: Lessons for the diabetes educator. Diabetes Educ 1995;21:33-37.
42. Becker G. Disrupted Lives: How People Create Meaning in a ChaoticWorld. Berkeley:University of California Press, 1997.
43. Meiwald C. Is awareness enough? The contradictions of selfcare in a chronic disease clinic. Hum Organ 1997;56:353-363.
44. Good MJ, Good B, Schaffer C, Lind S. American oncology and the discourse of hope. Cult Med Psych 1990;14:59-79.
45. Lakoff G, Johnson M. Metaphors We Live By. Chicago: University of Chicago Press, 1980.
46. Scheer J, Luborsky M. Cultural context of polio biographies. Orthopedics 1991;14:1173-1181.
47. Hays R, Kravitz R, Mazel R, Sherbourne C. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med 1994;17:347-360. (Pubitemid 24255227)
48. Bernard HR. Research Methods in Anthropology: Qualitative and Quantitative Approaches. Oxford: Altimira, 2001.
49. Ezzy D. Lived experience and interpretation in narrative theory: Experiences of living with HIV/AIDS. Qual Sociol 1998;21:169-179.
50. Ezzy D. Illness narratives: Time, hope and HIV. Soc Sci Med 2000;50:605-617.
51. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355:2283-2296.
52. Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care 2006;18:140-148. (Pubitemid 41780173)
53. Cohen J. Statistical Power Analysis for the Social Sciences. Hillsdale NJ: Earlbaum, 1988.